| 000 | 01895 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517223021.0 | ||
| 264 | 0 | _c20190620 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1016/j.ahj.2018.01.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuk, Adriana | |
| 245 | 0 | 0 |
_aFirst spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. _h[electronic resource] |
| 260 |
_bAmerican heart journal _c09 2018 |
||
| 300 |
_a95-100 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xurine |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFurosemide _xadministration & dosage |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHospital Mortality _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Admission |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSodium _xurine |
| 650 | 0 | 4 |
_aSodium Potassium Chloride Symporter Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aUrinalysis _xmethods |
| 700 | 1 | _aGroarke, John D | |
| 700 | 1 | _aDesai, Akshay S | |
| 700 | 1 | _aMahmood, Syed Saad | |
| 700 | 1 | _aGopal, Deepa M | |
| 700 | 1 | _aJoyce, Emer | |
| 700 | 1 | _aShah, Sachin P | |
| 700 | 1 | _aLindenfeld, Joann | |
| 700 | 1 | _aStevenson, Lynne | |
| 700 | 1 | _aLakdawala, Neal K | |
| 773 | 0 |
_tAmerican heart journal _gvol. 203 _gp. 95-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2018.01.013 _zAvailable from publisher's website |
| 999 |
_c28535049 _d28535049 |
||